Museveni to Launch First Clinical Trial for COVID-19 Treatment

Kp Reporter·Health·

Share
Museveni to Launch First Clinical Trial for COVID-19 Treatment

President Yoweri Museveni will tomorrow, Wednesday launch the first clinical trial for the COVID-19 treatment. Don Wanyama, the Presidential press secretary...

President Yoweri Museveni will tomorrow, Wednesday launch the first clinical trial for the COVID-19 treatment.

Don Wanyama, the Presidential press secretary confirmed in a tweet that President Museveni will officiate at Uganda’s first clinical trial for the treatment of COVID-19 at Mulago Hospital.

“Tomorrow, Wednesday, starting 10am, @KagutaMuseveni will officiate as Uganda launches its first clinical trial for its COVID-19 vaccine[treatment]. Events will be relayed on @ubctvuganda,” Wanyama tweeted.

Ever since March 2020 when Uganda registered her first case of coronavirus, government has been working hard to combat the spread of the deadly virus and at the same time work out clinical trials for a possible vaccine which had eluded the entire globe until recently when UK had a break through. In September last year, the Ministry of Health commenced clinical trials to use COVID-19 Convalescent Plasma (CCP) in the treatment of COVID-19 patients.

Similarly, the Uganda Virus Research Institute (UVRI) has also been in partnership with Imperial College London to start the first Covid-19 vaccine trial in Uganda. Recently, Dr Monica Musenero, the senior presidential adviser on epidemics, who is coordinating the vaccine development process, told the media there is progress in search of COVID-19 vaccine.

In December, the Ministry of Health ordered for 9 million doses of the COVID-19 vaccine amid surging new infections in the country. The vaccines are expected to be in the country mid this year and the first batch is expected to cover only 20% of the country’s total population. If tomorrow’s first clinical trial becomes successful then government would have been saved from a huge burden of procuring these vaccines from European countries. As of January 26, Uganda’s COVID-19 cases stood at 39,261 and 318 deaths.

Advertisement
Share
Advertisement

Related Articles

More stories you may want to read next.

Museveni Invites UK Investors to Manufacture Vaccines in UgandaHealth

Museveni Invites UK Investors to Manufacture Vaccines in Uganda

President Yoweri Kaguta Museveni has called for cooperation between Uganda and the United Kingdom (UK) in pharmaceutical manufacturing, public health, and medical research. Meeting a UK delegation led by Ambassador Nimisha Madhvani at State House Entebbe, President Museveni invited British investors to set up local medicine and vaccine production facilities to serve the regional market.

Museveni Pledges Support for Factory to Manufacture Animal Vaccines in Mpigi  National

Museveni Pledges Support for Factory to Manufacture Animal Vaccines in Mpigi

President Yoweri Kaguta Museveni has backed the development of the HUVET Bio-Science Park in Mpigi District, calling it a major leap toward national vaccine sovereignty. Led by Iranian investor Eng. Hashem Azimi, the biotechnology hub will manufacture local animal vaccines, combat livestock diseases, and position Uganda as a regional center for veterinary biotechnology.

Advertisement
Advertisement